ArticleEuropean journal of nutrition2026
Consumption of sugar-sweetened beverages, non-sugar sweetened beverages, and their substitution and risk of type 2 diabetes: the HELIUS study.
Article in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
purposeThe association between non-sugar-sweetened beverages (NSSB), as a suitable alternative for sugar-sweetened beverages (SSB), and the risk of type 2 diabetes (T2D) remains unclear. This study aimed to investigate the association between the intake of SSB and NSSB, their substitutions with each other, and T2D risk.
methodsWe used a sub-sample of adults aged 18-70 years from the Healthy Life in an Urban Setting (HELIUS) study. Dietary data was assessed using ethnic-specific food frequency questionnaires. Multivariable-adjusted incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for T2D risk for SSB and NSSB and their substitutions of one serving (250 ml)/day were estimated using Poisson models.
resultsAmong the 2612 participants included, 141 incident cases of T2D were identified. After multivariable adjustment, higher NSSB intake was associated with an increased risk of T2D in the overall population (IRR
conclusionThese findings suggest that replacing SSBs with NSSBs may not confer a metabolic benefit and may be associated with a higher risk of T2D in specific subgroups. Further research is needed to clarify the mechanisms and subgroup-specific factors underlying these associations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.